MSM's benefits for human immune function were studied in an open-label clinical trial. A total 50 men and women were given OptiMSM, 2.6 grams per day for 30 days.17 The MSM was given as four 650 mg capsules-two in the morning and two in the afternoon-each day. Immune function was measured by questionnaire, which included three subsections of questions about upper respiratory health (the head, eyes, nose, and throat), lower respiratory health (the lungs and chest), and energy level. The data suggested MSM produced clinically significant support for the upper respiratory system after one week, the lower respiratory system after three weeks, and enhanced energy levels after two weeks. These benefits continued into the fourth and final week of the study. A subset of 16 participants who experienced the least benefit from the MSM were selected to continue taking OptiMSM for an additional 14 days, but at the higher dose of 5.2 grams per day. These individuals then reported experiencing significantly enhanced energy levels and superior overall respiratory scores.
While new research is exploring the potential of methylsulfonylmethane in promoting the maintenance of GI health18 and bone health,19 the current clinical evidence shows MSM provides meaningful support for the joints, for immune function, and for the body's antioxidant and overall protective capacities. MSM is proven very safe to take, very well tolerated, and effective at intakes as high as 6000 mg (6 grams) per day.
Scientific References:
1. Monograph. Altern Med Rev 2003;8:438-41.
2. Parcell S. Altern Med Rev 2002;7:22-44.
3. Lovelock JE, Magga RJ. Nature 1972;237:452-453.
4. Jacob SW, Herschler R. Annals of the NY Acad Sci 1983;411:xiii-xvii.
5. Pearson TW, Dawson HJ, Lackey HB. J Agric Food Chem 1981;29:1089-91.
6. Silva Ferreira AC, Rodrigues P, Hogg T, Guedes De Pinho P. J Agric Food Chem 2003;51:727-32.
7. Debbi EM, Agar G, Fichman G, others. BMC Complement Altern Med 2011;11:50.
8. Kim LS, Axelrod LJ, Howard P, others. Osteoarthritis Cartilage 2006;14:286-94.
9. Usha PR, Naidu MU. Clin Drug Investig 2004;24:353-63.
10. Ezaki J, Hashimoto M, Hosokawa Y, Ishimi Y. J Bone Miner Metab 2013;31:16-25.
11. Fisher-Wellman K, Bloomer RJ. Dyn Med 2009;8:1.
12. Kalman DS, Feldman S, Scheinberg AR, others. J Int Soc Sports Nutr 2012;9:46.
13. Maranon G, Munoz-Escassi B, Manley W, others. Acta Vet Scand 2008;50:45.
14. Beilke MA, Collins-Lech C, Sohnle PG. J Lab Clin Med 1987;110:91-6.
15. Kim YH, Kim DH, Lim H, others. Biol Pharm Bull 2009;32:651-6.
16. Hasegawa T, Ueno S, Kumamoto S, Yoshikai Y. Jpn Pharmacol Ther 2004;32.
17. Barrager E, Veltmann JR, Jr., Schauss AG, Schiller RN. J Altern Complement Med 2002;8:167-73.
18. Amirshahrokhi K, Bohlooli S, Chinifroush MM. Toxicol Appl Pharmacol 2011;253:197-202.
19. Joung YH, Lim EJ, Darvin P, others. PLoS One 2012;7:e47477.